stockrow
Saturday 7 November 2026
Export FTH’s income statement to Excel — free account
Faeth Therapeutics, Inc.
- EPS
- +78.2%
- Free cash flow
- −262.7%
Quarter to September 2026, against a year earlier
21.86
1.94
+9.74%
Follow FTH
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
5.06 | 14.39 | 19.69 | 16.12 |
Net Debt/EBITDA |
4.30 | 1.19 | 10.15 | 7.92 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.82 | 0.06 | 0.98 | 0.64 | |
Capex/Depreciation |
0.00 | (0.20) | 0.00 | (0.18) | |
Interest Coverage |
(190.65) | — | — | — | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(3.06) | (8.29) | (2.78) | (0.50) | |
Cash per Share |
16.80 | 156.58 | 33.04 | 6.76 | |
Shareholders Equity per Share |
14.74 | (106.00) | 30.65 | 6.23 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
14.74 | (106.00) | 30.65 | 6.23 | |
Free Cash Flow |
(3.86) | (10.74) | (15.67) | (13.00) | |
Working Capital |
17.26 | 190.04 | 179.08 | 166.81 | |
Capital Expenditures |
0.00 | (0.01) | 0.00 | 0.00 | |
Net Current Asset Value |
17.20 | (138.43) | 172.31 | 159.99 | |
| Other line items | |||||
Quick Ratio |
4.98 | 14.29 | 19.46 | 15.84 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(3.06) | (8.29) | (2.78) | (0.50) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
1.36 | 5.67 | 4.35 | 5.02 | |
Average Assets |
34.13 | 121.83 | 110.54 | 103.27 | |
Average Common Equity |
28.49 | (52.65) | 100.14 | 92.05 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 5 Nov 2026